tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NTLA is currently covered by 18 analysts with an average price target of $31.27. This is a potential upside of $20.89 (201.25%) from yesterday's end of day stock price of $10.38.
Intellia Therapeutics's activity chart (see below) currently has 282 price targets and 225 ratings on display. The stock rating distribution of NTLA is 70.73% BUY, 26.83% HOLD and 2.44% SELL.
Analysts average stock forecasts to be materialized ratio is 42.87% with an average time for these price targets to be met of 155.56 days.
Highest price target for NTLA is $48, Lowest price target is $5, average price target is $19.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 07-Nov-2025.
Currently out of the existing stock ratings of NTLA, 29 are a BUY (70.73%), 11 are a HOLD (26.83%), 1 are a SELL (2.44%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 19-Oct-2020
$7
$-3.38 (-32.56%)
$10
2 months 4 days ago
(07-Nov-2025)
9/12 (75%)
$-5.32 (-43.18%)
317
Buy
Since 06-Oct-2025
$21
$10.62 (102.31%)
$29
2 months 4 days ago
(07-Nov-2025)
3/7 (42.86%)
$8.68 (70.45%)
44
Hold
Since 28-Feb-2025
$5
$-5.38 (-51.83%)
$13
2 months 4 days ago
(07-Nov-2025)
1/6 (16.67%)
$-7.32 (-59.42%)
144
Hold
Since 07-Nov-2025
$12
$1.62 (15.61%)
$17
2 months 4 days ago
(07-Nov-2025)
2/6 (33.33%)
$-0.32 (-2.60%)
3
Buy
Since 05-Aug-2016
$14
$3.62 (34.87%)
$24
2 months 4 days ago
(07-Nov-2025)
4/8 (50%)
$1.68 (13.64%)
350
What is NTLA (Intellia Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NTLA (Intellia Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NTLA (Intellia Therapeutics)?
Which analyst is the currently most bullish on NTLA (Intellia Therapeutics)?
Which analyst is the currently most reserved on NTLA (Intellia Therapeutics)?
